Anixa Biosciences share price today

(ANIX)

Anixa Biosciences share price is $2.69 & ₹228.59 as on 21 Dec 2024, 2.30 'hrs' IST

$2.69

Market is closed - opens 8 PM, 23 Dec 2024

View live Anixa Biosciences share price in Dollar and Rupees. Guide to invest in Anixa Biosciences from India. Also see the sentimental analysis on Indian investors investing in Anixa Biosciences. Get details on the Indian mutual funds that are investing in Anixa Biosciences. Get Analyst recommendations and forecasts along with all the Anixa Biosciences's financials.

Anixa Biosciences share price movements

Today's Low: $2.58
Today's High: $2.69
$2.69
4.23%
Downside
Day's Volatility :4.23%
Upside
0.0%
52 Weeks Low: $2.15
52 Weeks High: $5.13
$2.69
20.26%
Downside
52 Weeks Volatility :58.19%
Upside
47.56%

Anixa Biosciences Returns

Period	Anixa Biosciences, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-16.72%	-11.1%	0.0%
6 Months	7.6%	-6.0%	0.0%
1 Year	-31.03%	2.7%	0.0%
3 Years	-7.56%	0.6%	-19.7%

Anixa Biosciences Key Statistics

in dollars & INR

Previous Close	$2.69
Open	$2.64
Today's High	$2.69
Today's Low	$2.5762
Market Capitalization	$86.6M
Today's Volume	$96.1K
52 Week High	$5.13
52 Week Low	$2.145
Revenue TTM	$0.0
EBITDA	$-13.1M
Earnings Per Share (EPS)	$-0.39
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-55.24%

How to invest in Anixa Biosciences from India?

It is very easy for Indian residents to invest directly in Anixa Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Anixa Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Anixa Biosciences or ANIX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Anixa Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Anixa Biosciences shares which would translate to 0.316 fractional shares of Anixa Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Anixa Biosciences, in just a few clicks!

Returns in Anixa Biosciences for Indian investors in Rupees

Investment Value

₹1,00,000

Anixa Biosciences investment value today

Current value as on today

₹1,33,222

Returns

₹33,222

(+33.22%)

Returns from Anixa Biosciences Stock

₹31,026 (false-31.03%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Anixa Biosciences

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Anixa Biosciences on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 0% more investors are searching Anixa Biosciences in the last 30 days versus the previous period.

Global Institutional Holdings in Anixa Biosciences

Vanguard Group Inc
4.33%
Davidson D A & Co
2.09%
Laird Norton Tyee Trust Co
1.93%
UBS Group AG
1.65%
Mission Wealth Management, LLC
1.58%
Geode Capital Management, LLC
1.02%

Analyst Recommendation on Anixa Biosciences

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Anixa Biosciences(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Anixa Biosciences

What analysts predicted

Upside of 215.99%

Current:

$2.69

Target:

$8.50

Insights on Anixa Biosciences

Price Movement
In the last 1 month, ANIX stock has moved down by -12.1%
ANIX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 64.5%
ANIX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 35.1%

Anixa Biosciences Technicals Summary

Sell

Neutral

Buy

Anixa Biosciences is currently in a neutral trading position according to technical analysis indicators.

Anixa Biosciences Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Anixa Biosciences, Inc.	-12.09%	7.6%	-31.03%	-7.56%	-6.27%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Anixa Biosciences, Inc.	NA	NA	NA	-0.42	-0.55	-0.35	NA	0.68
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Anixa Biosciences, Inc.	Buy	$86.6M	-6.27%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About Anixa Biosciences

itus develops and acquires patented technologies for the purposes of patent monetization and patent assertion. the company currently has 8 patent portfolios in the areas of key based web conferencing encryption, encrypted cellular communications, nano field emission display (“nfed”), micro electro mechanical systems display (“mems”), j-channel window frame construction, vpn multicast communications, internet telephonic gateway, and enhanced auction technologies. itus’s management team has over 30 years of combined experience in patent monetization and patent assertion, and has generated in excess of $150 million patent licensing revenues

Organization	Anixa Biosciences
Employees	4
CEO	Dr. Amit Kumar Ph.D.
Industry	Electronic Technology

Management People of Anixa Biosciences

Name	Title
Dr. Amit Kumar Ph.D.	CEO, Chairman & Co-Chair of CBAB
Mr. Michael J. Catelani CPA, MBA	President, COO, CFO & Corporate Secretary
Mr. John Roop	Senior Vice President of Engineering
Dr. Pamela D. Garzone Ph.D.	Chief Development Officer & Chair Breast Cancer Clinical Advisory Board

Important FAQs about investing in Anixa Biosciences from India :

What is Anixa Biosciences share price today?

Anixa Biosciences share price today stands at $2.69, Open: $2.64 ; Previous Close: $2.69 ; High: $2.69 ; Low: $2.58 ; 52 Week High: $5.13 ; 52 Week Low: $2.15. The stock opens at $2.64, after a previous close of $2.69. The stock reached a daily high of $2.69 and a low of $2.58, with a 52-week high of $5.13 and a 52-week low of $2.15.

Can Indians buy Anixa Biosciences shares?

Yes, Indians can invest in the Anixa Biosciences (ANIX) from India.

With INDmoney, you can buy Anixa Biosciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Anixa Biosciences at zero transaction cost.

How can I buy Anixa Biosciences shares from India?

It is very easy to buy Anixa Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Anixa Biosciences be purchased?

Yes, you can buy fractional shares of Anixa Biosciences with INDmoney app.

What are the documents required to start investing in Anixa Biosciences stocks?

To start investing in Anixa Biosciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.